Mammographic fibroglandular density, bilateral breasts
ICD-10 R92.323 is a billable code used to indicate a diagnosis of mammographic fibroglandular density, bilateral breasts.
Mammographic fibroglandular density refers to the composition of breast tissue as seen on a mammogram. It is characterized by varying proportions of fibrous and glandular tissue compared to fatty tissue. Bilateral fibroglandular density indicates that both breasts exhibit this density pattern. High fibroglandular density can obscure the detection of breast cancer on mammograms, making it a significant factor in breast cancer screening and diagnosis. Women with dense breast tissue may have a higher risk of breast cancer, necessitating additional imaging or screening methods. Symptoms associated with this finding may include breast pain or discomfort, although many women may be asymptomatic. Clinical findings may include palpable masses or changes in breast contour, which should be evaluated further. The assessment of fibroglandular density is crucial for radiologists and clinicians in determining the appropriate follow-up and management strategies for patients.
Detailed patient history, including family history of breast cancer and any symptoms.
Routine screening mammograms revealing dense breast tissue.
Consideration of risk factors for breast cancer and appropriate referrals for further imaging.
Acute care notes should include any presenting symptoms and relevant imaging results.
Patients presenting with breast pain or palpable masses.
Rapid assessment and documentation of findings to facilitate timely referrals.
Used during routine screening for breast cancer.
Mammography report must indicate findings of fibroglandular density.
Radiology must ensure accurate reporting of breast density.
R92.323 indicates the presence of bilateral mammographic fibroglandular density, which may affect breast cancer screening and diagnosis.
Document the mammography report, patient symptoms, and any follow-up imaging recommendations to support the diagnosis.